HYTN Awarded Medical Cannabis Sales Licence By Health Canada
HYTN Cannabis Inc., wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has been awarded a license by Health Canada allowing for the sale of cannabis for medical purposes.
Rainbow Washing: How Insincere Branding Tarnishes Pride And Similar Celebrations Of Communities
Brands will likely get in on the action if a holiday or point of remembrance is coming up.
A Brief Overview: How Cannabis And LGBTQ Rights Reform Have Intertwined Through The Decades
The cannabis and LGBTQ rights movements have been connected from the beginning, as they mutually supported reform throughout the decades.
"Arguably, neither would exist as they do today if not for the other," said Tyme Ferris, founder and CEO of cannabis brand Pantheon Collective.
HYTN Innovations Receives Health Canada’s Approval To Sell Cannabis
HYTN Innovations Inc.’s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.
Emerald Health Therapeutics Leaving ‘Saturated’ Cannabis Market, Will Focus On Pharmaceuticals
Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) announced Monday that it is getting out of the recreational and medical cannabis industry and pivoting to pharmaceutical development.
Emerald Health’s Partner, Flower Pod, Launches Unique Dose-Controlled Cannabis Vaporizer
Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) announced that its partner, FlowerPod LLC has launched a “first-of-its-kind” cannabis vaporizer puck, dubbed HUUE™ and that it has teamed up with cann